Mylan

Official page for Mylan, where we work around the clock and around the globe to help provide 7 billion people access to high quality medicine

Edit Profile

mylan.com
B2c

More info

Elsewhere

Alexa global traffic share

Twitter followers

Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Apps 7

Add info

Employees

Team size

10000+

Locations

Unknown

Help us complete this profile

72% of Mylan shareholders think Heather Bresch is doing great—just overpaid

Strategy

Mylan board survives shareholder vote, but gets pushback on its compensation

Strategy

With help of coal tax credits, Mylan had a negative 294-percent tax rate in 2016

Stock markets Strategy

Mylan chairman: Drug pricing critics ought to go copulate with themselves

Costs Communities Health

How Mylan got away with overcharging Medicaid $1.3 billion for EpiPen

Health Privacy

Mylan shareholders revolt, say directors’ greed has gone too far

Stock markets

Mylan bullied, sued states to get them to use EpiPens, court documents show

Legal Health

FDA lashes out at Mylan for dismal quality control at HIV drug facility

Health

Despite what Mylan said, its price hikes hit patients’ wallets hard

Health Costs Earnings

EpiPen maker Mylan is under investigation by the Federal Trade Commission

US elections

For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million

Health Costs Privacy

Feds Go After Mylan For Scamming Medicaid Out of Millions On EpiPen Pricing

, via

Mylan CEO misled lawmakers about EpiPen profits—they’re 66% higher

Earnings

EpiPen maker Mylan may have used illegal deals with schools to price gouge

Costs Legal

Elizabeth Warren just demanded Mylan come clean about one of the biggest secrets in pharma

Costs Health

EpiPen maker Mylan reveals generic—it’s only triple the price

Costs Earnings

Bio Roundup: Mylan's Shock, Hillary's 3%, Duchenne Lessons & More

Health

Mylan CEO “frustrated” by own price gouging but doesn’t lower EpiPen price

Costs Health

EpiPen maker Mylan will make its allergy treatment more affordable

Costs Health

Index

By TNW

Mylan

Mylan

mylan.com

B2c

Elsewhere

Alexa global traffic share

Twitter followers

Overview

Apps 7

Team size

72% of Mylan shareholders think Heather Bresch is doing great—just overpaid

Mylan board survives shareholder vote, but gets pushback on its compensation

With help of coal tax credits, Mylan had a negative 294-percent tax rate in 2016

Mylan chairman: Drug pricing critics ought to go copulate with themselves

How Mylan got away with overcharging Medicaid $1.3 billion for EpiPen

Mylan shareholders revolt, say directors’ greed has gone too far

Mylan bullied, sued states to get them to use EpiPens, court documents show

FDA lashes out at Mylan for dismal quality control at HIV drug facility

Despite what Mylan said, its price hikes hit patients’ wallets hard

EpiPen maker Mylan is under investigation by the Federal Trade Commission

For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million

Feds Go After Mylan For Scamming Medicaid Out of Millions On EpiPen Pricing

Mylan CEO misled lawmakers about EpiPen profits—they’re 66% higher

EpiPen maker Mylan may have used illegal deals with schools to price gouge

Elizabeth Warren just demanded Mylan come clean about one of the biggest secrets in pharma

EpiPen maker Mylan reveals generic—it’s only triple the price

Bio Roundup: Mylan's Shock, Hillary's 3%, Duchenne Lessons & More

Mylan CEO “frustrated” by own price gouging but doesn’t lower EpiPen price

EpiPen maker Mylan will make its allergy treatment more affordable

Mylan N.V. Reports Solid Q1 Revenue Growth, With Europe Leading the Way